Perineal Acupoint Therapy for Breast Hyperplasia
The perineal acupoint (Ren 1, or Huiyin) has been explored in traditional Chinese medicine (TCM) as an adjunctive therapeutic target for benign breast conditions, including mammary gland hyperplasia—a
The perineal acupoint (Ren 1, or Huiyin) has been explored in traditional Chinese medicine (TCM) as an adjunctive therapeutic target for benign breast conditions, including mammary gland hyperplasia—a common, non-cancerous proliferation of breast ductal and stromal tissue often associated with cyclical breast pain, tenderness, and palpable nodularity.
According to TCM theory, the Ren Mai (Conception Vessel) meridian—of which Huiyin is the first point—regulates the flow of Qi and blood through the lower abdomen and pelvic region and exerts influence over reproductive and endocrine functions. Stimulating Huiyin is believed to harmonize liver Qi, resolve stagnation, and modulate hormonal fluctuations implicated in mammary hyperplasia, particularly those linked to estrogen-progesterone imbalance.
Clinical practice typically involves gentle manual pressure, moxibustion, or low-intensity electroacupuncture applied to Huiyin under strict sterile and ethical protocols. It is never used as monotherapy but rather integrated into a comprehensive TCM treatment plan that may include herbal formulations (e.g., Xiao Yao San or Ru Pi Xiao), lifestyle counseling, and other acupoints such as Zhongji (Ren 3), Zusanli (ST 36), and Taichong (LR 3).
While preliminary observational studies and case series suggest potential symptomatic improvement—including reduced mastalgia and decreased nodule size—robust clinical evidence from randomized controlled trials remains limited. Current guidelines from major integrative oncology and breast health societies emphasize that Huiyin stimulation should complement, not replace, conventional diagnostic evaluation (e.g., clinical breast exam, ultrasound, or biopsy when indicated) and evidence-based management strategies.
Practitioners must exercise caution: Huiyin is contraindicated during pregnancy, active pelvic infection, recent perineal trauma or surgery, and in patients with compromised immune status. Treatment should only be administered by licensed, board-certified acupuncturists with specialized training in women’s health and strict adherence to anatomical safety standards.